These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 7543270)
1. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1. Fujihashi T; Sakata T; Kaji A; Kaji H AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine. Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine. Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623 [TBL] [Abstract][Full Text] [Related]
4. Effects of tubeimoside-1 on HIV core protein p24 and cytopathogenesis in vitro. Yu LJ; Ma RD; Jiang SB Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):103-6. PubMed ID: 8010099 [TBL] [Abstract][Full Text] [Related]
5. Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase. McMahon JB; Gulakowski RJ; Weislow OS; Schultz RJ; Narayanan VL; Clanton DJ; Pedemonte R; Wassmundt FW; Buckheit RW; Decker WD Antimicrob Agents Chemother; 1993 Apr; 37(4):754-60. PubMed ID: 7684215 [TBL] [Abstract][Full Text] [Related]
6. Short, terminally phosphorylated oligoriboguanylic acids effectively inhibit cytopathicity caused by human immunodeficiency virus. Fujihashi T; Sakata T; Kaji A; Kaji H Biochem Biophys Res Commun; 1994 Sep; 203(2):1244-50. PubMed ID: 7916572 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents. Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387 [TBL] [Abstract][Full Text] [Related]
8. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication. Steinkasserer A; Harrison R; Billich A; Hammerschmid F; Werner G; Wolff B; Peichl P; Palfi G; Schnitzel W; Mlynar E J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548 [TBL] [Abstract][Full Text] [Related]
9. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 in CEM cells by a potent TAR decoy. Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112 [TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of compounds for anti-HIV activity. Patience C; Moore J; Boyd M Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by daphnodorins. Yusa K; Oh-hara T; Tsukahara S; Baba K; Taniguchi M; Kozawa M; Takeuchi S; Hara H; Tsuruo T Antiviral Res; 1994 Sep; 25(1):57-66. PubMed ID: 7529015 [TBL] [Abstract][Full Text] [Related]
13. Effects of serotonin and melanin on in vitro HIV-1 infection. Sidibe S; Saal F; Rhodes-Feuillette A; Lagaye S; Pelicano L; Canivet M; Peries J; Dianoux L J Biol Regul Homeost Agents; 1996; 10(1):19-24. PubMed ID: 9049777 [TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity. Konopka K; Pretzer E; Celada F; Düzgüneş N J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz. Prochaska HJ; Bornmann WG; Baron P; Polsky B Mol Pharmacol; 1995 Jul; 48(1):15-20. PubMed ID: 7542738 [TBL] [Abstract][Full Text] [Related]
16. Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors. Lee DS; Jung KE; Yoon CH; Lim H; Bae YS Antimicrob Agents Chemother; 2005 Oct; 49(10):4110-20. PubMed ID: 16189087 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664 [TBL] [Abstract][Full Text] [Related]
18. Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus. Kim SG; Suzuki Y; Nakashima H; Yamamoto N; Takaku H Biochem Biophys Res Commun; 1991 Sep; 179(3):1614-9. PubMed ID: 1930201 [TBL] [Abstract][Full Text] [Related]
19. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity. Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528 [TBL] [Abstract][Full Text] [Related]
20. The proteinase inhibitor pepstatin A inhibits formation of reverse transcriptase in H9 cells infected with human immunodeficiency virus 1. Grinde B; Hungnes O; Tjøtta E AIDS Res Hum Retroviruses; 1989 Jun; 5(3):269-74. PubMed ID: 2471542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]